SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17/1/20.12.24

SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17/1/20.12.24 Stock

DE000SW7EPQ2

Market Closed - Börse Stuttgart 03:56:53 2024-05-30 EDT
1.71 ^EUR	-8.56%

Current month	+98.94%
1 month	+110.11%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Chart SG/CALL/TEVA PHARMACEUTICAL INDUSTRIES/17/1/20.12.24

Latest news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED

Teva Pharmaceutical Gains FDA Approval for Daily Huntington's Disease Pill	03:40am	MT
Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)	06:39pm	BU
Teva Pharmaceutical Industries Limited Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24?48 mg/day)	06:38pm	CI
Teva and Alvotech Announce SIMLANDI Injection Now Available in the U.S.	05-22	AQ

More news

Quotes 5-day view

Date	Price	Change
24-05-30	1.71	-8.56%
24-05-29	1.87	+5.65%
24-05-28	1.77	-2.21%
24-05-27	1.81	-4.74%
24-05-24	1.9	-8.21%

Delayed Quote Börse Stuttgart

Last update May 30, 2024 at 03:56 am

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer	Société Générale
WKN	SW7EPQ
ISIN	DE000SW7EPQ2
Date issued	2024-03-07
Strike	17 $
Maturity	2024-12-20 (204 Days)
Parity	1 : 1
Emission price	0.99 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	2.14 €
Lowest since issue	0.54 €
Spread	0.02 €
Spread %	0.95%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Sector

More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.45 USD

Average target price

17.84 USD

Spread / Average Target

+8.43%

Consensus